Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Alzheimer Drugs Market Research Reports

Titlepublishedprice

Alzheimer's Disease - Pipeline Review, H1 2017

By Global Markets Direct
"...... landscape. Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which......"
22-Mar-2017$2500

Global Dementia Partnering 2010 to 2017

By Current Partnering
"...... e Global Dementia Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • To......"
01-Feb-2017$1495

Global Alzheimer's Disease Partnering 2010 to 2017

By Current Partnering
"...... The Global Alzheimer's Disease Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partne......"
01-Feb-2017$1495

Namenda -Drug Insights, 2017

By Delve Insight
"...... des the Namenda sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Namenda, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Alzheimer's disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... he Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Alzheimer's disease (AD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global fo......"
01-Jan-2017$4950

Alzheimer's Disease-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Dementia Associated With Alzheimer's Disease-Pipeline Insights, 2017

By Delve Insight
"...... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ac......"
01-Jan-2017$1250

Alzheimer's disease (AD) - Epidemiology Forecast To 2023

By Delve Insight
"...... 's disease (AD) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Alzheimer's disease (AD). ......"
01-Jan-2017$2750

Dementia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... and the market and pipeline status of the drugs around the Dementia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the h......"
01-Jan-2017$2000

Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... of the Dementia Associated With Alzheimer's Disease Report is to understand the market and pipeline status of the drugs around the Dementia Associated With Alzheimer's Disease to explore the generic development opportunities, licensing opportunities ......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.